Share
Tomorrow we at SynBioBeta are hosting our online Chemicals & Materials Conference ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

View in Browser »

Hi ,

We hope this finds you well.

Tomorrow we at SynBioBeta are hosting our online Chemicals & Materials Conference, wherein we will bring the leading innovators, thought leaders, and creators of the bioeconomy together to celebrate and accelerate our progress in making bioplastics from captured chemical emissions, aviation fuel from microbes, leathers from mushrooms, and bricks from bacteria.

We believe these innovations (and more like them) will play a critical role in transforming our economy from carbon positive to carbon negative. But how can we integrate them into our existing societies? What consumer trends are driving growth in key sectors—and what consumer hesitancy is preventing growth in others?

If these topics interest you, please plan to join tomorrow from 8am-12pm PST to hear from and connect with leading experts in biomanufacturing, cosmetics, fuel, defense, consumer products, construction and so much more. Learn how you can incorporate biology into your supply chains and be a part of the movement to build a better world with biology!

Thank you for your kind consideration and hope to see you tomorrow!

Larry

Larry Upton

Editor in Chief

larry.upton@synbiobeta.com

Spotlight on: Meissa Vaccines

How can we stop a virus in its tracks? One of the best ways is to preempt a viral infection at the source. When it comes to respiratory viruses, including SARS-CoV-2 (which causes COVID-19), one of the first places an infection takes hold is in the nose. Meet Meissa Vaccines, the biotech company working to prevent respiratory virus infections with nasal spray vaccines. The company is engineering live viral vaccines that trigger a strong immune response but don’t cause disease. Learn more about how Meissa is transforming live attenuated vaccine technology to protect our populations!

Chemicals & Materials Digital Conference

November 17th, 2021

How do we build a sustainable world? Most of what we rely on in our daily lives, from our clothes to our homes, cars, medicines, tools, even the screen you’re reading this on right now, are made from unsustainable sources generating tons (literally) of carbon emissions. But what if we could build our modern world with biology instead?

Learn more »

The greener route to indigo blue

At Huue, they look at how dye molecules are made in nature. They study the biochemical pathways, then program Escherichia coli bacteria to make our dye in the same way.

Keep Reading »

Synthace raises $35M to expand access to its revolutionary R&D technology for life changing research

The company also plans to expand its senior leadership team in the U.S., with new vice presidents of marketing and sales joining the U.S.-based CEO.

Keep Reading »

Roswell Biotechnologies unveils first molecular electronics chip to digitize biology

The Roswell ME Platform integrates single molecules into electronic circuits acting as sensor elements to create the first fully scaled biosensors on standard semiconductor chips.

Keep Reading »

Twist Bioscience launches Revelar Biotherapeutics to develop COVID-19 and other antibody therapeutics

Revelar will have the ability to leverage the antibody discovery and optimization platform of Twist Biopharma to license additional antibodies for up to five targets over the next four years.

Keep Reading »

Book your hotel room for the event at special rates!
Meet some of our speakers.

MORE TO EXPLORE

CRISPR Therapeutics and ViaCyte, Inc. to start clinical trial of the first gene-edited cell replacement therapy for treatment of type 1 diabetes

Keep Reading »

How to turn your ideas into patents

Keep Reading »

Amyris closes upsized offering of $690.0 million of 1.50% convertible senior notes due 2026

Keep Reading »

GenScript launches closed-end double-stranded DNA service for CRISPR

Keep Reading »

LanzaTech: Radically rethinking industrial business models

Keep Reading »

Pheronym begins scaling pest bio-control solution at Lawrence Berkeley National laboratory

Keep Reading »

Codex DNA acquires Eton Bioscience

Keep Reading »

We've Got More »

WHO'S HIRING?

    Bioinformatics Software Engineer, Inscripta, Pleasanton, CA or Boulder, CO


    Senior Bioinformatics Software Engineer, Inscripta, Pleasanton, CA


    Scientist/ Senior Scientist, Inscripta, Pleasanton, CA


    Scientist – Synthetic DNA Production, Upstream Process, Generation Bio, Cambridge, MA


    Business Development Director, Calyxt, Remote Worker


    VP, Process Chemistry & Manufacturing, Calyxt, Remote Worker


    Synthetic Biologist, Robigo, Cambridge, MA


    SynBio Fungal Scientist, Allonnia, Boston, MA


    Environmental Microbiologist, Allonnia, Boston, MA


    Scientist II, Automated Strain Engineering, IFF, Palo Alto, CA


    Field Applications Scientist (FAS): Inscripta – Europe

      Access The Job Board »

      Like our Digest? Please feel free to share with friends, family, and co-workers!


      SynBioBeta, LLC
      3559 Mount Diablo Boulevard #2, Lafayette, CA 94549

      info@synbiobeta.com

      If you no longer wish to receive our emails, you can unsubscribe here.
      Modify Your Email Preferences


      Email Marketing by ActiveCampaign